ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: WHO Begins Project To Urge Governments To Establish “National Cancer Programs”

October 30, 1998

In Brief: Comprehensive Centers “Jewel In Crown” Of Cancer Program, DeVita Says; Boutwell New NCAB Member

February 18, 1983

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004